FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer and Expands Mounjaro Indication for Cardiovascular Risk Reduction
The United States Food and Drug Administration (FDA) has ushered in a transformative era for both oncology and cardiometabolic medicine…
